7733

OLYMPUS CORPORATION

オリンパス株式会社
Healthcare · Medical Devices
Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.
← Companies
Price
¥1,786
Market Cap
¥2.0T
Ent. Value
¥2.1T
Net Debt
−¥51.5B
Shares Out.
1.1B
P / E
29.1×
EV / EBIT
21.3×
P / Book
2.42×
P / NCAV
N/M
Div. Yield
1.68%
Financials
Metric FY 2025
TDnet
FY 2024
TDnet
FY 2023
EDINET ↗
FY 2022
EDINET ↗
FY 2021
EDINET ↗
Net Sales ¥1,010.7B ¥1,010.7B ¥936.2B ¥881.9B ¥868.9B
Cost of Sales ¥356.6B ¥356.6B ¥311.1B ¥285.1B ¥297.2B
Gross Profit ¥654.1B ¥654.1B ¥625.1B ¥596.8B ¥571.7B
SG&A ¥507.1B ¥507.1B ¥473.2B ¥420.5B ¥405.4B
Operating Income ¥97.1B ¥97.1B ¥43.6B ¥186.6B ¥153.9B
Non-Operating Income ¥3.4B ¥2.6B ¥3.9B ¥1.4B
Non-Operating Expenses ¥6.8B ¥10.3B ¥8.2B ¥5.4B
Ordinary Income ¥143.3B ¥188.5B
Pre-tax Income ¥94.0B ¥94.0B ¥35.9B ¥182.3B ¥149.9B
Net Income (owners) ¥68.2B ¥68.2B ¥242.6B ¥143.4B ¥115.7B
Minority Interest ¥363M ¥181M ¥228M
Comprehensive Income ¥113.5B ¥316.4B ¥196.7B ¥161.0B
EBITDA ¥164.3B ¥164.3B ¥109.5B ¥253.3B ¥218.5B
EPS ¥61.32 ¥61.32 ¥199.91 ¥113.22 ¥90.22
Shares Outstanding 1.13B 1.17B 1.25B 1.27B
Shares Issued (total) 1.14B 1.22B 1.27B 1.30B
Treasury Shares 11.3M 49.5M 12.6M 26.3M